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Abstract
Although the incidence of and mortality following ST-segment elevation myocardial infarction 
(STEMI) is decreasing, time-trends in anatomical location of STEMI and associated short-term 
prognosis have not been examined in a population-based community study. We determined 22-
year trends in age- and race-adjusted, gender-specific incidence rates and 28-day case fatality of 
hospitalized STEMI by anatomic infarct location among a stratified random sample of 35-74 year 
old residents of four communities in the Atherosclerosis Risk in Communities (ARIC) study. 
STEMI infarct location was assessed by 12-lead electrocardiograms (ECG) from the hospital 
record, and was coded as anterior, inferior, lateral and multi-location STEMI using the Minnesota 
Code. Between 1987 and 2008, a total of 4,845 patients had an incident STEMI; 37.2% were 
inferior STEMI; 32.8% were anterior; 16.8% occurred in multiple infarct locations and 13.2% 
were lateral STEMI. For inferior, anterior and lateral STEMI in both men and women, significant 
declines were observed in the age-adjusted annual incidence rate and the associated 28-day case 
fatality. In contrast, for STEMI in multiple infarct locations, neither the annual incidence rate nor 
the 28-day case fatality changed over time. The age- and race-adjusted annual incidence rate and 
associated 28-day case fatality of STEMI in anterior, inferior and lateral infarct locations declined 
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over 22 years of surveillance; however, no decline was observed for STEMI in multiple infarct 
locations. In conclusion, our findings suggest there is room for improvement in the care of patients 
with multi-location STEMI.
Keywords
ST segment elevation myocardial infarction; Epidemiology; Trends
Introduction
Detailed evaluation of temporal trends in myocardial infarction (MI) rates is essential to 
monitor the population burden of cardiovascular disease (CVD), and to understand the 
determinants of coronary heart disease (CHD) mortality over time.1 During a STEMI, the 
distribution of ST-elevations on a surface electrocardiogram (ECG) corresponds to anatomic 
locations of ischemic myocardium 2 and has prognostic importance.3 Recent studies have 
demonstrated declines in the incidence,1,4,5 severity,6, 7 and mortality after an MI.1,5 Some 
STEMI consensus treatment guidelines 7 and clinical practice monographs 8 draw from 
historic patterns in STEMI infarct location, and suggest that STEMI treatment may differ by 
infarct location.9 However, whether patterns of STEMI infarct location by ECG have 
changed and apply to STEMI in the contemporary era is unknown. We describe herein 
twenty-two year trends in rates of incident STEMI by ECG infarct location and associated 
survival in a community setting.
Methods
Since 1987, the Atherosclerosis Risk in Communities (ARIC) study has conducted 
surveillance of hospitalized MI and deaths due to CHD among residents 35 to 74 years of 
age in four communities: Forsyth County, North Carolina; Jackson, Mississippi; suburban 
Minneapolis, Minnesota; and Washington County, Maryland. The combined study 
population of these four communities was approximately 396,000 persons in 2008. Twenty-
four percent of the population in ARIC communities under surveillance were black. Forsyth 
County, North Carolina and the city of Jackson, Mississippi were 20% and 50% black, 
respectively, while the remaining two communities in ARIC Community Surveillance are 
predominantly white.6 Details of the surveillance methods used have been previously 
reported and are only briefly described here.10,11
A stratified random sample of suspected hospitalized MIs was identified from electronic 
discharge lists obtained from all hospitals (n=23) serving the four communities.6 Trained 
ARIC staff abstracted data from medical records, selected on age, community of residence 
and discharge code (ICD-9-CM codes 402, 410-414, 427, 428, and 518.4). Detailed 
descriptions of investigation and validation of selected ICD codes used in ARIC surveillance 
have been provided elsewhere.12,6 Sampling probabilities varied by race, sex, field center 
and discharge code stratum and were adjusted periodically.13 Medical records were 
abstracted for presence of chest pain, history of MI or CVD and cardiac biomarkers.7 Copies 
of up to three ECGs (first, last and third) were obtained from each hospitalization and sent to 
the University of Minnesota Electrocardiographic Reading Center for classification by the 
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Minnesota Code.14,15 A computerized algorithm was applied to data on chest pain, 
biomarkers and electrocardiographic findings to classify MI.10 Criteria for each of these 
three diagnostic elements in the algorithm remained constant over the study period and have 
been described in detail.5 All eligible hospitalized events were classified as definite, 
probable, suspect or no MI.10 Definite and probable MI were combined to define MI events 
for this analysis. Definite and probable MI events with abnormal biomarkers were further 
classified by Minnesota Code of the ECGs obtained as ST-segment elevation MI (STEMI) 
or non ST-segment elevation MI (NSTEMI).14 This analysis was restricted to validated 
STEMI events without a history of prior MI noted in the medical record.
All ECGs were visually coded using Minnesota code categories of ST-segment elevations 
into one of four anatomic locations based on conventional anatomic grouping of surface 
ECG leads: V1-V5; II, III, AVF; or I, AVL, V6. Using these three lead groups, four 
anatomic locations (anterior, inferior, lateral or multiple) were derived for this study. 
Anterior STEMI was defined as ST-segment elevation ≥ 2.0mm in any of leads V1-V4 or an 
ST-segment elevation ≥ 1.0mm in V5; inferior STEMI as ST-segment elevation ≥ 1.0mm in 
any of leads II, III or aVF; and lateral STEMI as ST-segment elevation ≥ 1.0mm in any of 
leads I, aVL, and V6 alone or in the presence of anterior ST-segment elevations.16,6 ST-
elevations in the anterior and lateral ECG lead-groups were combined to increase sensitivity 
to detect lateral STEMI, as ischemia of the lateral wall may be poorly represented by the 
lateral leads (I, aVL, V6) alone.17,18 Finally, to represent ischemia in multiple anatomic 
locations, a multi-location STEMI was defined as ST-segment elevations in 2 or more of 
anterior, inferior or lateral locations.
Vital status post-hospital discharge was determined through linkage with the National Death 
Index (NDI). Twenty-eight day case fatality was determined for all incident STEMI cases 
and, due to limited events by infarct location, we grouped 28-day case-fatality into two time 
period categories (1987-1996 and 1997- 2007) for comparison. Case fatality results are not 
reported for 2008 due to a lag in NDI reporting.
All analyses were weighted and standard errors were computed using stratified random 
sampling methodology to account for the sampling scheme.5,12,21 Descriptive statistics for 
baseline characteristics were computed by year group and by STEMI infarct locations. The 
annual percent changes in event rates were computed across the year groups for each 
baseline characteristic, and the corresponding standard errors were approximated by the 
delta method. Wald tests were used to compare baseline characteristics between STEMI 
locations. Age- and race-adjusted, sex-specific, annual incidence rates per 10,000 persons of 
STEMI by anatomic location were computed based on population denominator estimates 
using interpolation and extrapolation of 1990 and 2000 U.S. Census population estimates. 
Age and race adjustment was by the direct method using the 2000 U.S. population estimates 
as the standard. Twenty-two year trends in incident STEMI are reported by location and 
gender based on linear or quadratic Poisson regression models. Quadratic trends are reported 
only when the quadratic term in the model is significant at the 0.05 level. Pairwise 
comparisons of the bootstrapped average annual percent change estimated from the location-
specific linear regression models were made at the 0.05 level with Bonferroni adjustment for 
multiple comparisons. Logistic regression was used to model age and race-adjusted 28-day 
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case fatality percentages as a function of location, time interval (1987-1996 and 1997-2007), 
and gender. Contrasts were specified to test differences in case fatality between year-groups 
for each location. The differences of trends in case fatality trends between genders were 
tested; gender-specific trends were not reported due to insignificant p-values and small 
numbers of events. Event-rate trends analysis was conducted in the statistical package 
SUDAAN Loglink and case fatality analyses were conducted in SUDAAN Logistic.
Results
From 1987 through 2008, there were an estimated 4,845 incident hospitalized STEMIs in the 
four ARIC study communities among residents 35 to 74 years of age. Over the twenty-two 
year study period, 31.3% of STEMIs occurred in women. There were statistically significant 
changes in both the characteristics of STEMI patients and the methods used to treat these 
patients over the study duration (Table 1).
Overall for all years combined, 37.2% of STEMIs were inferior; 32.8% anterior; 16.8% 
occurred in multiple infarct locations; and 13.2% were lateral. There were differences in age 
and race by STEMI infarct location (Table 2).
For all STEMI infarct locations combined, from 1987 through 2008 there was an age- and 
race-adjusted average annual decrease in STEMI incidence rates in both men and women for 
inferior, anterior and lateral STEMI (Table 3 and Figure 1). The decline was most notable 
for inferior STEMI in men (Table 3 and Figure 2). In contrast, there was no substantial 
change in the rates of STEMI in multiple infarct locations for either men or women. A 
quadratic trend was observed in anterior STEMIs for both genders; trends in the remaining 
locations and genders were linear with a statistically significant difference between the 
inferior and multiple location trends in both genders.
Overall, the 28-day age- and gender-adjusted case fatality for STEMI decreased from 8.9% 
(95% CI 7.5, 10.1) in 1987-1996 to 5.4% (95% CI 4.1, 6.6) in 1997-2007. Changes in age-
and gender-adjusted 28-day case fatality from 1987-96 to 1997-2007 differed significantly 
among STEMI locations (P value = 0.041). The decline in age and gender-adjusted 28-day 
case fatality from 1987-96 to 1997-2007 was statistically significant for anterior, inferior 
and lateral STEMI (Table 4). In contrast, no significant change in 28-day case fatality for 
multi-location STEMI was observed.
Discussion
The principle findings of this investigation are that between 1987 and 2008 (1) the rate and 
28-day case fatality for inferior, anterior and lateral STEMI declined while (2) the rate and 
28-day case fatality for multi-location STEMI did not change. By 2008, multi-location 
STEMI was the second most common and had the highest 28-day case fatality. The 
difference in rates and outcomes by anatomic location may relate to the distribution of CAD 
risk factors in the ARIC study population. Obesity, diabetes and hypertension have remained 
prevalent in the United States19,20 and the age at first MI has increased.21 Older age, 
diabetes and hypertension are risk factors for multi-vessel CAD,22,23 and may increase risk 
for multi-location STEMI.
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There are several potential explanations as to why the 28-day case fatality for multi-location 
STEMI did not improve. First, infarct size is an independent predictor of post-MI 
prognosis 24 and is likely greater for multi-location versus single anatomic location STEMI. 
Second, multi-location STEMI has been associated with multi-vessel CAD and poor 
prognosis after an MI.25 Third, percutaneous revascularization may be more difficult in 
patients with multi-vessel CAD and multi-location STEMI.26 Lastly, incomplete 
revascularization has been associated with poor post-MI prognosis 27 and may be more 
common in patients with multi-location STEMI and multi-vessel CAD.
As in other studies,28 we observed a shift in STEMI revascularization strategies over time 
from urgent CABG and thrombolytics towards the widespread use of PCI. However, the 
increase in PCI was not associated with improved 28-day case fatality for multi-location 
STEMI. This finding may have implications for the revascularization of patients with multi-
vessel CAD, including patients with multi-location STEMI. 34
Strengths of our study include the population-based design; the inclusion of African-
Americans from multiple communities in the United States; and the standardized validation 
of events and ECG coding. To our knowledge, no other study has used surveillance ECG 
data to detail trends in rates of STEMI by anatomic location.
The main imitation of the current study is the imprecise nature of the surface ECG to 
localize infarct location.30 However, the ECG lead-groups used represent large regions of 
myocardium with prognostic value,3 and are more accurate than administrative codes of 
STEMI location.4 While multi-location STEMI may indicate multi-vessel CAD, multi-
location STEMI could arise from proximal CAD or from a coronary artery subtending 
multiple regions of myocardium. Since STEMI diagnosis is much less biomarker dependent 
than NSTEMI,4,5 the lack of biomarker adjustment in our study is unlikely to have 
significantly affected our findings. We do not have information on STEMI infarct location 
for patients who died before reaching a hospital in the ARIC surveillance study. However, 
sudden cardiac death as an initial manifestation of CAD has decreased over time,29 and is 
therefore unlikely to have altered our findings.
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Figure 1. Age- and race-adjusted Average Annual Percent Change of STEMI by Infarct 
Location, stratified by gender: The ARIC Study – Community Surveillance, 1987-2008
Key:
Abbreviations: STEMI, ST elevation myocardial infarction
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Figure 2. Age- and race-adjusted Annual Rates (per 10,000 persons) of STEMI by Infarct 
Location, stratified by gender: The ARIC Study – Community Surveillance, 1987-2008
Key:
Abbreviations: STEMI, ST elevation myocardial infarction
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